Synmosa Biopharma Corporation (SYNMOSA BIOPHARMA CORP) aksje
4114.TWO
StengtSYNMOSA BIOPHARMA CORP
Market Cap
$15,501,094,912
Om Synmosa Biopharma Corporation (SYNMOSA BIOPHARMA CORP) aksje
Synmosa Biopharma Corporation, a specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally. It offers medicines for urology, hormones, oncology, dermatology, cardiovascular, CNS, gastrointestinal, and other areas; and effervescent tables, granules, and nasal sprays. The company is also involved in provision of cosmetics, veterinary drugs, chemical food additives, and beverages; wholesale retail of environmental drugs; and import and export of related businesses. The company was founded in 1959 and is based in Taipei, Taiwan.
Selskapsinformasjon
114 Taipei, Taiwan
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.